Related Experiment Video
Updated: Aug 6, 2026
05:28
A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Factors affecting the pharmacokinetic characteristics of rapacuronium
D M Fisher1, R Kahwaji, D Bevan
1Department of Anesthesia, University of California, San Francisco 94143-0648, USA. fisher@zachary.ucsf.edu
Anesthesiology
|April 14, 1999
Summary
Age and gender do not affect rapacuronium elimination in patients. This study found no influence of these factors on the muscle relaxant
Area of Science:
- Pharmacology
- Anesthesiology
- Clinical Pharmacology
Background:
- Rapacuronium is a novel nondepolarizing muscle relaxant known for its rapid onset and offset.
- Understanding its pharmacokinetic profile is crucial for optimizing clinical use.
Purpose of the Study:
- To investigate the influence of age, gender, and other covariates on the pharmacokinetic characteristics of rapacuronium.
- To analyze the impact of demographic and laboratory values on rapacuronium's elimination.
Main Methods:
- Population pharmacokinetic analysis using mixed-effects modeling.
- Sparse plasma sampling from 43 patients (aged 24-83 years) receiving rapacuronium.
- Measurement of rapacuronium and its metabolite ORG9488 plasma concentrations.
Main Results:
- Rapacuronium's weight-normalized plasma clearance is influenced by hemoglobin levels.
- Age, gender, and other examined covariates did not significantly affect rapacuronium's weight-normalized pharmacokinetic parameters.
- Plasma concentrations of the metabolite ORG9488 were minimal, contributing little to neuromuscular blockade.
Conclusions:
- Neither age nor gender impact rapacuronium elimination in this patient cohort.
- Findings contrast with previous studies suggesting age-related clearance changes.
- The metabolite ORG9488's contribution to neuromuscular blockade is negligible at studied concentrations.
Related Concept Videos
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:30Factors Affecting Drug Distribution: Tissue Permeability
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...